Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
| Image |  |
|---|---|
| Description | scientific article published on 18 September 2017 |
| Author/s |
author: Steven M Horwitz |
| Publication date | September 18, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |